![](https://imageio.forbes.com/specials-images/imageserve/66b32e1ea0f8ae06b582bce1/0x0.jpg?format=jpg&crop=5200,2927,x0,y269,safe&height=900&width=1600&fit=bounds)
Ozempic Maker Novo Nordisk Sinks On Disappointing Earnings
Topline Shares of pharma giant Novo Nordisk fell Wednesday after the Danish firm reported lower-than-expected profits for the second quarter and a slimmed-down profit outlook for the year, as it faces growing competition in the market for weight loss drugs …